arrow
P

Pietro Iaffaldano

University of Bari Aldo Moro
H指数:30
被引数:3,443

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Validation of generative artificial intelligence techniques for synthetic data generation in multiple sclerosis research: A comparison with real-world evidence from the Italian multiple sclerosis registry

生成式人工智能技术在多发性硬化症研究中合成数据生成中的验证:与意大利多发性硬化症登记处真实世界证据的比较

2026-10-140
PRE
Profiling the long-term risk of severe adverse events in a cohort of multiple sclerosis patients treated with different treatment sequences: Results from the Italian Multiple Sclerosis and Related Disorders Registry (I-MS&RD) (ProSA study)

评估接受不同治疗方案序列治疗的视神经脊髓炎患者队列中长期严重不良事件风险的概况:意大利视神经脊髓炎及相关疾病登记研究(I-MS&RD)(ProSA研究)结果

2026-07-040
PRE
A predictive tool for early treatment escalation after initiation of moderate-efficacy therapy in pediatric-onset multiple sclerosis

儿科起病多发性硬化中度疗效治疗后早期强化治疗的预测工具

2026-06-010
PRE
Safety assessment of switching from fingolimod to siponimod: An Italian multicenter prospective study

从 fingolimod 切换到 siponimod 的安全性评估:一项意大利多中心前瞻性研究

2025-07-010
PRE
Home-based, computer-assisted cognitive rehabilitation for attention in pediatric onset multiple sclerosis: a randomized, multicenter pilot study

居家计算机辅助注意力认知康复在儿童期发病多发性硬化中的应用:一项随机、多中心试点研究

2024-11-250
PRE
Disability trajectories by progression independent of relapse activity status differ in pediatric, adult and late-onset multiple sclerosis
2024-08-230
OAAI
A comparison of natalizumab and ocrelizumab on disease progression in multiple sclerosis

那他珠单抗和ocrelizumab对多发性硬化疾病进展的比较

2024-07-053
OA
Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries

控制小儿多发性硬化症患者残疾恶化的疾病改善疗法: 全球和国家注册机构的纵向分析

2024-05-014
PRE